pre-update Archives

Announcement

Certara Launches Early Development Solution to Reduce Failure Rates in Early-Stage Drug Development

New solution offers early-stage developers a dedicated team of experts with combined experience in end-to-end…

Certara2024年9月19日

Conference

International Congress of Parkinson’s Disease and Movement Disorders®

Danielle Pillsbury2024年9月18日

Publication

A close examination of BCRP’s role in lactation and methods for predicting drug distribution into milk

The article, authored by Caroline Sychterz, Hong Shen, Yueping Zhang, Michael Sinz, Amin Rostami-Hodjegan, Brian…

Danielle Pillsbury2024年9月18日

Press Release

サターラとIchnos Glenmarkとの提携により、画期的な抗がん剤の投与戦略を最適化

Preclinical research on the trispecific antibody, ISB 2001, published in Nature Cancer leveraged virtual trials to…

Danielle Pillsbury2024年9月18日

Publication

ISB 2001 trispecific T cell engagerは、強力な腫瘍細胞毒性を示し、多発性骨髄腫細胞の免疫回避機構を克服します。

Abstract Despite recent advances in immunotherapies targeting single tumor-associated antigens, patients with multiple myeloma eventually…

Renee Fisher2024年9月18日

Publication

Towards a Platform Quantitative Systems Pharmacology (QSP) Model for Preclinical to Clinical Translation of Antibody Drug Conjugates (ADCs)

Abstract A next generation multiscale quantitative systems pharmacology (QSP) model for antibody drug conjugates (ADCs)…

Renee Fisher2024年9月18日

Publication

A Next Generation Mathematical Model for the in vitro to Clinical Translation of T-cell Engagers

Abstract T-cell engager (TCE) molecules activate the immune system and direct it to kill tumor…

Renee Fisher2024年9月18日

Publication

Mechanistic PK/PD modeling to address early-stage biotherapeutic dosing feasibility questions

Abstract Incorporating an early evaluation of dosing requirements is crucial for assessing the viability of…

Renee Fisher2024年9月18日

オンデマンド・ウェビナー

オンデマンド [ISoP ウェビナー] – モデルを活かした医薬品開発（MIDD）における生理学的薬物動態（PBPK）の応用 – 規制当局の現状の受け入れ状況をご存知ですか？

Model Informed Drug Development (MIDD) is a critical component in the drug development process and…

Danielle Pillsbury2024年9月16日

Guide

A Best Practice Guide to Managing Non-CRF Data

Danielle Pillsbury2024年9月16日

Powered by Translations.com GlobalLink Web Software

pre-update

Certara Launches Early Development Solution to Reduce Failure Rates in Early-Stage Drug Development

International Congress of Parkinson’s Disease and Movement Disorders®

A close examination of BCRP’s role in lactation and methods for predicting drug distribution into milk

サターラとIchnos Glenmarkとの提携により、画期的な抗がん剤の投与戦略を最適化

ISB 2001 trispecific T cell engagerは、強力な腫瘍細胞毒性を示し、多発性骨髄腫細胞の免疫回避機構を克服します。

Towards a Platform Quantitative Systems Pharmacology (QSP) Model for Preclinical to Clinical Translation of Antibody Drug Conjugates (ADCs)

A Next Generation Mathematical Model for the in vitro to Clinical Translation of T-cell Engagers

Mechanistic PK/PD modeling to address early-stage biotherapeutic dosing feasibility questions

オンデマンド [ISoP ウェビナー] – モデルを活かした医薬品開発（MIDD）における生理学的薬物動態（PBPK）の応用 – 規制当局の現状の受け入れ状況をご存知ですか？

A Best Practice Guide to Managing Non-CRF Data

メルマガ登録

クイックアクセス

ソリューション

お問合せ